Home  >  Products  >  BPHL (biphenyl hydrolase-like (serine hydrolase) ) Blocking Peptide (the N terminal of BPHL)(100ug)
BPHL (biphenyl hydrolase-like (serine hydrolase) ) Blocking Peptide (the N terminal of BPHL)(100ug)

BPHL (biphenyl hydrolase-like (serine hydrolase) ) Blocking Peptide (the N terminal of BPHL)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BPHL Antibody (ARP61857_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61857
Size: 100ug
Weight: 30kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a member of the serine protease family of hydrolytic enzymes which contain a serine in their active site. The encoded protein may play a role in activation of the antiviral prodrug valacyclovir. Alternatively spliced transcript variants have been described.
Alternative names: BPH-RP; MCNAA; MGC125930; MGC41865; VACVASE
See Full Product Listings >